About BalancePhase
BalancePhase is an independent editorial operation that publishes consumer research on dietary supplements, nootropics and wellness products sold in the United States, United Kingdom and the European Union.
We started BalancePhase because the supplement market has a transparency problem. Ingredient lists are routinely hidden behind proprietary blends. Prices are structured around subscriptions that are difficult to cancel. Marketing claims borrow the language of clinical research without ever citing it. Consumers are left making health-adjacent purchasing decisions with almost no reliable information about what they are actually buying.
Our work is an attempt to fix that, one product at a time.
What we do
For each product we review, we work through three questions:
- What is actually inside the formula? We check whether every ingredient and its dose is disclosed on the label, and compare it against published regulatory requirements for labelling.
- What does the product actually cost? We separate the advertised headline price from the real cost of a subscription, including renewal terms and cancellation conditions.
- Do the claims hold up? We check marketing claims against the FDA, EFSA and MHRA registers of authorised health claims. Where a claim cannot be verified, we say so in the review.
Every review is published with its methodology, its sources and its limitations stated explicitly. Our full approach is documented on the Methodology page.
What we do not do
We are not a medical resource.
BalancePhase does not provide medical advice, diagnosis or treatment recommendations. Nothing published on this site should be used as a substitute for consultation with a qualified physician, pharmacist or registered dietitian. If you are taking prescription medication, are pregnant or breastfeeding, or have a diagnosed medical condition, speak to a healthcare professional before starting any supplement.
We also do not conduct laboratory testing ourselves. When we reference testing, we cite the laboratory and the published result. When a product has not been independently tested, we state that plainly rather than implying otherwise.
Who is responsible
BalancePhase operates as an independent editorial entity. W. H. Neves is responsible for editorial decisions, review accuracy and corrections. The research is produced by a small editorial team working across English, German and Dutch language markets.
How we are funded
BalancePhase is funded through affiliate commissions. When a reader buys a product through a link on our site, we may receive a commission from the retailer or manufacturer at no additional cost to the reader.
This model has an obvious conflict of interest, and we address it in two ways. First, a product's commercial relationship with us has no bearing on its evaluation — we publish negative assessments, including recommendations not to buy, on the same terms as positive ones. Second, every page that contains affiliate links carries a disclosure at the top, before the content begins. Our Affiliate Disclosure page sets out the full detail.
Our markets
BalancePhase currently publishes for the United States, United Kingdom, Germany and the Netherlands. Content is written for the regulatory framework of each market rather than translated from a single master version — a health claim permitted by the FDA may not be permitted by EFSA, and our reviews reflect that.
Corrections
If you believe something we published is inaccurate, contact us at editorial@balancephase.com. We review every correction request and update the article where warranted, with a note explaining what changed. Our full process is described in the Editorial Policy.
Editorial enquiries: editorial@balancephase.com
Corrections and factual challenges: editorial@balancephase.com